Owl Creek Asset Management’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Owl Creek Asset Management’s Portfolio STLN Stock Details STLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-199,996	Closed	-$2.01M	–	122
2020 Q2	$2.01M	Buy	+199,996	New	+$1.99M	0.15%	44

Other funds holding STLN

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Owl Creek Asset Management's STLN Position: Q3 2020 in Review

Owl Creek Asset Management sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q3 2020, closing a stake of 199,996 shares — an estimated $2.01M sold.

Owl Creek Asset Management first reported a position in STLN in Q2 2020 and held it in 1 quarter. The position peaked at $2.01M in Q2 2020. 38 funds tracked by Wall St. Rank hold STLN as of Q3 2020.

Owl Creek Asset Management reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Owl Creek Asset Management sold 199,996 Starling Oncology Institute, Inc. Common Stock shares in Q3 2020, an estimated $2.01M.
Owl Creek Asset Management first reported a position in Starling Oncology Institute, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
Owl Creek Asset Management's Starling Oncology Institute, Inc. Common Stock position peaked at $2.01M in Q2 2020.
38 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q3 2020.

Based on Owl Creek Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.